CIK 0001802665 · Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822279923
- Phone
- (484) 539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,108,586
- in 2 filings
Net −$3,108,586. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | Sender Gary Director | Grant or award · Stock Option | +9,613 | 48,255 | ||
| 2023-05-25 | Graf R. Mark Director | Grant or award · Stock Option | +5,224 | 21,816 | ||
| 2023-05-25 | Sabater Juan A. Director | Grant or award · Stock Option | +5,224 | 26,224 | ||
| 2023-05-25 | Gracias Antonio J. Director | Grant or award · Stock Option | +7,314 | 36,714 | ||
| 2023-05-25 | Szyper Linda M Director | Grant or award · Stock Option | +5,224 | 15,693 | ||
| 2023-03-29 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise | +30,000 | 30,000 | ||
| 2023-03-29 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −15,414 | $33.36 | $514K | 14,586 |
| 2023-03-29 | Kapadia Sandip CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −30,000 | 30,000 | ||
| 2022-12-14 | Nielsen Jack Director | Sale | −2,834 | $59.96 | $170K | 2,571,024 |
| 2022-12-14 | Wicki Andreas Director | Sale | −130 | $60.00 | $8K | 2,147,943 |
| 2022-12-13 | Wicki Andreas Director | Sale | −6,320 | $60.13 | $380K | 2,148,073 |
| 2022-12-12 | Wicki Andreas Director | Sale | −22,391 | $60.36 | $1.4M | 2,154,393 |
| 2022-12-09 | Nielsen Jack Director | Sale | −9,847 | $59.89 | $590K | 2,573,858 |
| 2022-12-08 | Nielsen Jack Director | Sale | −36,878 | $59.90 | $2.2M | 2,583,705 |
| 2022-12-07 | Nielsen Jack Director | Sale | −64,026 | $60.35 | $3.9M | 2,620,583 |
| 2022-12-05 | Wicki Andreas Director | Sale | −77,853 | $61.23 | $4.8M | 2,176,784 |
| 2022-12-02 | Serafin Andrew CHIEF STRATEGY OFFICER | Option exercise | +38,000 | $8.22 | $312K | 38,000 |
| 2022-12-02 | Serafin Andrew CHIEF STRATEGY OFFICER | Sale | −37,080 | $60.12 | $2.2M | 920 |
| 2022-12-02 | Serafin Andrew CHIEF STRATEGY OFFICER | Sale | −920 | $60.71 | $56K | 0 |
| 2022-12-02 | Serafin Andrew CHIEF STRATEGY OFFICER | Option exercise · Stock Option | −38,000 | 83,729 |
Page 12 of 14 · 268 trades